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Children and adolescents living with human immunodeficiency virus (CA-HIV) suffer a
considerable burden of internalizing disorders (IDs; depressive and anxiety disorders).
Environmental and genetic factors have been reported to influence the vulnerability
to IDs in western settings; however, their role among African populations remains
inadequately explored. We investigated the individual and interactive effects of stress
and single-nucleotide polymorphisms within the FK506 binding protein 5 (rs1360780)
and glucocorticoid receptor (rs10482605) genes on ID status in a cohort of CA-HIV
in Uganda. We genotyped rs10482605 (309 cases and 315 controls) and rs1360780
(350 cases and 335 controls) among CA-HIV with and without IDs using Kompetitive
Allele-Specific PCR. Socio-demographic variables, as well as allele and genotype
distributions, were compared between cases and controls using chi-square tests.
Genotypes were assessed for Hardy–Weinberg equilibrium. Composite indices of recent
and chronic stress classes were also generated. A hierarchical cluster analysis was used
to generate cutoff points within each of the indices of recent and chronic stress. Logistic
regression was used to assess the association between IDs and each of recent stress,
chronic stress, and the investigated genotypes. The interaction effect of chronic/recent
stress on the association between each of the polymorphisms and IDs was determined
using a likelihood ratio test. We observed no significant association between IDs
and rs1360780 and rs10482605 polymorphisms within the FKBP5 and glucocorticoid
receptor genes, respectively (P > 0.050). Severe recent stress increased the vulnerability
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to IDs among CA-HIV (P = 0.001). We did not observe any gene–environment effect on
vulnerability to IDs in this population. These findings support the currently held opinion
that polymorphisms at single genetic loci only contribute a very small effect to the genetic
vulnerability to IDs.
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INTRODUCTION
Poor mental health has been recognized as a neglected global
health burden, particularly for children and adolescents (1).
Globally, 10–20% of children suffer from life-related disabilities
arising from mental health disorders, including psychiatric
disorders, general psychological distress, and emotional and
behavioral problems (2). However, studies on mental health
among children and adolescents have lagged considerably behind
that of adults, especially in the African continent (3). Children
and adolescents with human immunodeficiency virus (CA-HIV)
represent one of the groups with a significant burden of mental
health disorders (4, 5). A study conducted in the United States
reported a higher prevalence of psychiatric cases in children with
HIV compared to the general pediatric population (6.17 vs. 1.7
cases per 1,000 person-years) (6). Evidence for the adverse effects
of HIV infection on mental health has also been found in sub-
Saharan African populations (7), with a systematic review of 14
studies indicating a 25% prevalence for any psychiatric disorder
and a 30–50% prevalence of psychological distress or emotional
or behavioral difficulties in adolescents with HIV (8). One of the
groups of mental illness that CA-HIV suffer from is internalizing
disorders (IDs; depressive and anxiety disorders) (5, 9, 10).
Internalizing disorders are most often characterized by quiet,
internal distress, which may be described as “intropunitive,”
rather than overt, socially negative, or disruptive behavior that
characterizes externalizing disorders (11). The most prevalent
and commonly diagnosed IDs include depression and anxiety,
with studies from both Africa and the United States reporting
ranges between 4–72 and 5–82%, respectively (5, 12). In Uganda,
an epidemiological study, on which this analysis is based,
reported the prevalence of IDs as 11.5% and of major depressive
disorder as 3.9% and any anxiety disorder as 9.0% (5).
The risk factors for IDs in CA-HIV are multifactorial and
include the direct and indirect effects of HIV neurotoxicity
(13). Similarly, environmental risk factors such as bereavement,
extreme poverty, food insecurity, and deprivation of basic needs
have also been implicated in IDs (14, 15). These environmental
factors predispose to acute/recent and/or chronically stressful
life conditions, which shape the onset, temporal course, and
consequences of depressive and anxiety disorders (16, 17). IDs
have been associated with poor school performance, impaired
social relationships and reduced drug adherence, risky sexual
behavior as well as impaired quality of life (14, 15).
A familial history of psychiatric illness among children and
adolescents has been demonstrated to be associated with IDs,
lending credence to the role of genetic factors in determining
internalizing disorder risk (18). Genetic polymorphisms within
the neurotransmitter and neuropeptide signaling systems—for
instance, brain-derived neurotropic factor (rs6265, rs10835210,
and rs11030107) (19), dopamine transporter gene (20),
monoamine oxidase A (21), and serotonin transporter (22)
genes, have been associated with IDs in healthy children and
adolescents in the western world. Albeit that the psychiatric–
genomic data in African populations is limited, a study
undertaken in Uganda (23) reported a significant association
between polymorphisms of the serotonin transporter gene and
suicidality among adults living withHIV/AIDS. Notably, the only
study to date that has investigated genetic factors associated with
psychiatric disorders among CA-HIV has reported a significant
interaction between recent stress and the SA haplotype of the
serotonin-transporter-gene-linked polymorphic region, which
was associated with higher odds of being an ID case (24).
On the other hand, genetic studies conducted in non-HIV-
infected populations have reported associations between genes
within the stress response-hypothalamic-pituitary-adrenal axis
(HPA) and vulnerability to depression and anxiety. In particular,
vulnerability to IDs has been associated with single-nucleotide
polymorphisms (SNPs) within both the FK506 binding protein
51 (FKBP5) gene, which encodes a glucocorticoid receptor (GR)
co-chaperone that is involved in the HPA axis negative feedback
(25, 26), and the nuclear receptor subfamily-3 group-C member-
1 (NR3C1) gene, which encodes the GR protein (27, 28). SNPs
such as rs3800373, rs9296158, rs1360780, rs9470080, rs4713916,
rs3000377, and rs47139611 in FKBP5 (25, 26) and rs414232,
rs6195, rs6189, rs10482605, and rs6190 in NR3C1 (27, 28) are
postulated to interact with early trauma or childhood adversity
to predict negative outcomes later in life, such as vulnerability to
IDs (29, 30). TheminorC allele of the rs10482605 polymorphism,
located within the promoter region of NR3C1, is associated
with a reduced expression of the GR protein and has been
inversely associated with the liability to develop IDs in non-HIV-
infected subjects (27, 28). Similarly, rs1360780, a SNP located
in an enhancer region 488 bp away from a glucocorticoid
response element in intron 2 of FKBP5, moderates the GR-
mediated expression of FKBP5 (25, 26). Several groups reported
an association between FKBP5 variants and IDs using American,
German, and Polish non-HIV cohorts (31–33). However, other
studies involving Spanish, Swedish, and Italian populations
failed to replicate these findings (34–36). Whether common
variants in FKBP5 are associated with vulnerability to IDs thus
remains inconclusive.
Additionally, these studies have been conducted among
non-HIV-infected adults, primarily in populations of European
ancestry. Therefore, the prevalence of these SNPs and their
association with vulnerability to IDs (depression and anxiety) in
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an African population of CA-HIV is unclear. We investigated GR
and FK506 binding protein genotypes and stress as predictors of
IDs among CA-HIV from Kampala andMasaka districts. Finally,




This was a nested case-control study utilizing archived
whole blood samples collected during a Medical Research
Council/Department for International Development
(MRC/DFID)-funded project entitled “Mental health among
children and adolescents living with HIV/AIDS in Kampala and
Masaka districts of Uganda” (CHAKA study). The aim of the
CHAKA study was to investigate the epidemiology of psychiatric
disorders among CA-HIV in Uganda and the implications of
these for service provision (5). The present study investigated the
association between stress on the one hand and selected stress
hormone pathway gene polymorphisms on the other with IDs
among CA-HIV.
Study Participants and Site
The CHAKA parent study enrolled a total of 1,339 children
and adolescents [855 children (5–11 years) and 484 adolescents
(12–17 years)] from two HIV clinics in Kampala (Joint Clinic
Research Centre and Nsambya Home Care) and three HIV
clinics in Masaka (The Aids Support Organization-Masaka,
Kitovu Mobile Clinic, and Uganda Cares). The participants were
recruited and assessed for psychiatric disorders (including IDs)
and socio-demographic factors at three time points (baseline and
at months 6 and 12 months) by trained psychiatric nurses and
psychiatric clinical officers between December 2014 and August
2016 (5). All study participants were on antiretroviral treatment
(ART). The current study is comprised of a total of 736 cases
and matched control participants [389 children (5–11 years)
and 307 adolescents (12–17 years)] who were recruited into the
CHAKA study.
Inclusion and Exclusion Criteria
The following were the inclusion and exclusion criteria for the
CHAKA study:
Inclusion criteria: (i) CA-HIV (with children defined as aged
between 5 and 11 years and adolescents defined as aged between
12 and 17 years), and (ii) able to speak English or Luganda (the
local language spoken in the study areas) and expected to remain
in the study area for the subsequent 12 months.
Exclusion criteria: (i) concurrent enrollment in another
study, (ii) sick and in need of immediate medical attention,
and (iii) those unable to understand the study instruments for
whatever reason.
The current study included all children (aged 5–11 years)
and adolescents (aged 12–17 years) with IDs and their
case-matched controls (children and adolescents without any
psychiatric disorder). Details about the prevalence of psychiatric
disorders diagnosed in the CHAKA study, including internalizing
disorders considered in the current study, have been included in
Supplementary Table 1.
Selection of Cases and Controls
The selection of cases and controls was as described elsewhere
(37). Briefly, the cases were children/adolescents who had any
IDs. All cases at baseline were ascertained, and the cases were
then stratified by site (one of two sites), sex, age category (one of
three categories), and socio-economic status (SES; one of three
SES categories). This resulted in a total of 36 strata (2 × 2 ×
3 × 3). In each stratum, the number of cases was ascertained
(e.g., for males in site 1 in the youngest age category and the
lowest SES group, there were nine cases). An equal number of
controls (children/adolescents without any psychiatric disorder)
were then randomly sampled from the stratum concerned (so
for males in site 1 in the youngest age category and the lowest
SES group, nine controls were sampled). Thus, the controls were
frequency matched to the cases on site, sex, age, and SES.
Power Calculation
We conducted a post-hoc power analysis for this study.
The sample size calculation was done using an online
calculator (http://osse.bii.a-star.edu.sg/calculation1.php). The
default setting for a case–control study was used, with
significance level of 5%, minor allele frequency in cases of 15%,
minor allele frequency in controls of 7%, and ratio of cases to
controls at 1:1. Given 309 cases and an equal number of controls
with complete genotypic data, our study achieved a power of 89%.
Assessment of Psychiatric Disorders and
Socio-Demographic Factors
The details of the procedures has been published elsewhere
(37). Psychiatric disorders, including IDs, were assessed using
the Children and Adolescent Symptoms Invetory-5 (CASI-5)
(Gadow and Sprafkin, 2013). The CASI-5 has been locally
adapted for use in Uganda (38). The CASI-5 was administered
by trained psychiatric nurses and psychiatric clinical officers at
two time points (baseline and 12 months). Individual CASI-
5 items are rated on a four-point frequency of occurrence
scale ranging from never (0) to very often (3). The socio-
demographic characteristics for both the participants and their
caregivers were collected using a socio-demographic proforma
developed by the Mental Health Section of the MRC/Uganda
Virus Research Institute and LSHTM Uganda Research Unit.
The socio-economic status was generated from a scale of nine
household items (car, motorcycle, refrigerator, electricity, bicycle,
radio, telephone, cupboard, and flask). Each itemwas weighted in
the respective order, with a car carrying a maximum weight of 9
and a flask a minimum weight of 1. A total score of the items was
generated, whose median cutoff of 13 was used to classify low and
high SES. A score <13 was classified as low SES, while that >13
was classified as high SES.
Assessment of Chronic and Recent Stress
The chronic and recent stress classes used in this study were
generated by Kalungi et al. (37). Briefly, social disadvantage
was used as a proxy of chronic stress, with a composite index
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constructed based on the following variables: orphanhood, food
availability, study site, and level of education of the caregiver.
Hierarchical cluster analysis (HCA) was used to generate the
different cutoff points for each of the chronic stress classes:
mild with chronic stress scores of 0–1.375, moderate with
scores ranging from 1.375 to 2.375, and severe with scores
>2.375. A composite index for recent stress was constructed
from the following variables: caregiver mental state, child–
caregiver relationship, and HIV symptoms. Three recent stress
classes were generated using HCA, i.e., mild with scores <0.362,
moderate with scores between 0.362 and 0.622, and severe with
scores >0.622.
DNA Extraction
Genomic DNA was extracted from a whole-blood specimen
for each participant using the Qiamp mini DNA extraction
kit (Qiagen GmbH, Germany), following the instructions of
the manufacturer. Extracted DNA was quantified by ultraviolet
spectrophotometry on NanoDrop 1000 spectrophotometer V3.7
(Thermo Fisher Scientific, Wilmington, MA). The DNA was
subsequently diluted to 5 ng/µl, and 5 µl of each of the DNA
samples was run on 1% agarose gel to assess the quality. The
extracted DNA was then stored for ∼3 months at −20◦C while
awaiting further molecular analysis.
Kompetitive Allele-Specific PCR
Genotyping
The Kompetitive Allele-Specific PCR (KASP) genotyping of
rs10482605 (within NR3C1) and rs1360780 (within FKBP5)
polymorphisms was conducted by LGC Genomics Ltd.,
United Kingdom. Briefly, the PCR reaction was carried out in 10
µl of reaction mixture containing 5 µl of 2X KASP master mix,
KASP assay mix (primers) at 0.14 and 5 µl (5 ng/µl) of genomic
DNA. The DNA sample was diluted to a final concentration of
5–10 ng per reaction. All reagents were vortex-mixed prior to
use. The cycling conditions were as follows: one cycle of hot
start activation at 94◦C for 15min, followed by 10 cycles of
denaturation, annealing, and extension at 94◦C for 20 s and
61–55◦C for 60 s (dropping 0.6◦C per cycle), respectively. A
further 26 cycles were performed, consisting of denaturation at
94◦C for 20 s and annealing and extension at 55◦C for 60 s (39).
Distilled water and PCR mixture without the DNA template
were included on each genotyping plate as negative controls. A
difference in fluorescent signal intensity between the presence
and absence of template DNA allowed improved confidence in
the validity of the genotyping results. Individual samples that
failed to genotype for a particular SNP were removed from
the analysis.
Statistical Analysis
Statistical analyses were conducted using Stata 15 (StataCorp, TX,
USA). The socio-demographic characteristics (including SES)
were dichotomized and described between cases and controls.
The socio-economic status and chronic and recent stress were
measured as described by Kalungi et al. (37). Hierarchical cluster
analysis was used to generate the different cutoff points for
each of the chronic and recent stress classes (mild, moderate,
and severe). Chi-square tests were used to assess the differences
between the socio-demographic characteristics according to ID
status at baseline (cases vs. controls). The allele frequencies of
the studied genes were tested for Hardy–Weinberg equilibrium
(HWE), and the distribution of genotype in cases and controls
was compared using chi-square tests. Any possible relationship
between polymorphisms in each gene and ID was investigated
using chi-square tests. Logistic regression models were used to
investigate the association between recent stress, chronic stress,
genotypes, and IDs and to calculate the odds ratio and 95%
confidence intervals. In these models, recent and chronic stress
were included as predictor variables, SNPs were entered as
covariates, and ID case-control status was the binary outcome
variable. The interaction effect of chronic stress/recent stress
on the association between the polymorphisms (rs10482605
and rs1360780) and IDs was tested using a likelihood
ratio test.
Ethical Considerations
The present study was nested in a parent study (37), which
obtained ethical and scientific clearance from the Uganda
Virus Research Institute Science and Ethical Committee
(#GC/127/15/06/459) and the Uganda National Council
of Science and Technology (#HS 1601). Written informed
consent was obtained from all the caregivers for their
children/adolescents to participate in the study and for a
blood specimen to be drawn from their children/adolescents for
genetic analyses. The adolescents provided further written
informed assent to participate in the study. The study
participants diagnosed with significant psychiatric problems
were referred to the mental health units at Entebbe and
Masaka government hospitals. Personal identifiers and data
were kept under lock and key and were only available to the
study team. Administrative clearance was obtained from the
Uganda Virus Research Institute—MOH for the use of the
archived samples.
RESULTS
Socio-Demographic Characteristics of the
Study Participants
A total of 736 participants (389 children and 307 adolescents)
were enrolled into this study from the Kampala and Masaka
districts. Out of the 736, about 44% were from Kampala,
and 56% were recruited from Masaka. The subjects were
purposively selected and age- and sex-matched based on
the availability of 368 presenting with at least one ID,
hence giving both controls and cases equal representation
of 50% (368/736 each). The rs10482605 polymorphism was
assessed in 624 (309 cases and 315 controls) participants
with complete data, while 685 participants (335 controls and
350 cases) had complete data for inclusion in the rs1360780
polymorphic analysis. The socio-demographic characteristics did
not differ by disease status (Table 1). The socio-demographic
characteristics were analyzed as described in the “Statistical
Analysis” section.
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TABLE 1 | Distribution of socio-demographic characteristics between cases and controls.
Characteristics Controls, n (%) Cases, n (%) Total, n (%) P
Gender
Female 207 (56.40) 186 (50.54) 393 (53.47) 0.111
Male 160 (43.60) 182 (49.46) 342 (46.53)
Age category
Adolescents 149 (42.45) 158 (45.80) 307 (44.11) 0.374
Children 202 (57.55) 187 (54.20) 389 (55.89)
Educational level
No formal education 9 (2.45) 4 (1.09) 13 (1.77) 0.371
Pre-primary 323 (88.01) 325 (88.80) 648 (88.40)
Secondary 35 (9.54) 37 (10.11) 72 (9.82)
Socio-economic status
High 197 (53.53) 207 (56.25) 404 (54.89) 0.459
Low 171 (46.47) 161 (43.75) 332 (45.11)
Study site
Kampala 165 (44.84) 156 (42.39) 321 (43.61) 0.504
Masaka 203 (55.16) 212 (57.61) 415 (56.39)
n, number of participants; %, percentage; children, 5–11 years; adolescents, 12–17 years.
Distribution of the rs10482605 and
rs1360780 Minor Allele Frequencies and
Genotypes Between Cases and Controls
The comparison between minor allele frequencies of both
rs10482605 (within NR3C1) and rs1360780 (within FKBP5)
SNPs in the studied population and other ethnicities is shown
in Table 2. The minor allele frequencies of rs10482605 and
rs1360780 polymorphisms were 0.121 and 0.396, respectively, in
this study population.
Frequencies and Genotype Distribution of NR3C1
rs10482605
The rs10482605 polymorphism was assessed in 624 (309 cases
and 315 controls) participants with complete data. In particular,
out of 315 participants without IDs, five carried the homozygous
minor GG genotype for the rs10482605 polymorphism, while
60 and 250 participants carried the heterozygous GA and wild-
type AA forms, respectively. Similarly, out of 309 subjects with
IDs, four possessed the homozygous minor GG genotype of
the rs10482605 polymorphism; 73 and 232 were heterozygous
and homozygous wild type, respectively. In comparison, 44.44
and 55.56, 54.89 and 45.11, and 48.13 and 51.87% of cases and
controls possessed the mutant, heterozygous, and wild type of
the NR3C1 genotypes, respectively (Table 3). According to the
results of a chi-square test, there was no significant difference
in the frequencies and genotype distribution of the rs10482605
polymorphism between cases and control populations (P >
0.369). The frequency of the minor G allele in the rs10482605
polymorphic site was 0.121 among the population studied
(Table 2). The genotype distribution for the subjects did not
significantly deviate from HWE (P = 0.9595).
Frequencies and Genotype Distribution of FKBP5
rs1360780
A total of 685 participants (335 controls and 350 cases) had
complete data for inclusion in the rs1360780 polymorphic
analysis, as shown inTable 2. The number of individuals carrying
the homozygous minor TT, heterozygous CT, and wild-type
CC genotypes were 60, 154, and 121, respectively, among the
controls and 51, 166, and 133, respectively, among the cases
(Table 3). The genotype frequencies were 54.05 and 45.95%,
48.13 and 51.88%, and 47.64 and 52.36% for homozygous
minor TT, heterozygous CT, and wild-type CC among controls
and cases, respectively (Table 3). There was no significant
difference observed in the frequency and distribution of the
different genotypes between the cases and controls for the
rs1360780 polymorphism using the chi-square test (P = 0.492).
In addition, the genotype distribution for subjects did not
significantly deviate from the HWE as evidenced by the non-
significant difference between the observed and expected alleles
and genotype values of the rs1360780 polymorphisms (P =
0.545). The minor allele T frequency in this population was
0.396 (Table 2).
Genotypic and Environmental Predictors of
IDs in CA-HIV From Kampala and Masaka
Districts—Uganda
A total of 309 cases had complete data for inclusion in the
analyses of the association between IDs and the potential risk
factors of the investigated SNPs and environmental factors (acute
and chronic stress). None of the allelic forms of the SNPs
studied had any significant influence on the increased likelihood
of developing IDs (Table 4). Using logistic regression analysis,
the decreased risk of developing IDs in individuals with the
G minor allele of the rs10142605 was not significant (P =
0.143) compared to individuals possessing the wild-type form.
In individuals carrying the homozygous minor T allele of the
rs1360780 variant, the odds of developing IDs was likewise
non-significantly reduced (P = 0.329). Recent stress (specifically
severe recent stress), as opposed to chronic stress, significantly
increased the likelihood of developing IDs in CA-HIV as shown
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TABLE 2 | Genome location and minor allele frequency of the rs10482605 and rs1360780 single nucleotide polymorphisms among different populations.
Genome location Minor allele frequency
Gene region Xsome Nucleotide change DBSNP Ref 1000G-Global 1000G-African Est Swe Sib Ug
NR3C1-promoter Chr5 A>G rs10482605 0.10 0.08 0.12 0.13 0.50 0.12
FKBP5-intron 2 Chr6 T>C rs1360780 0.33 0.42 0.26 0.28 0.24 0.39
Xsome, Chromosome; Est, Estonian; Swe, Sweden; Sib, Siberia; Ug, Uganda; DBSNP Ref, database single nucleotide polymorphism reference (allele frequency adopted from 1,000
genomes; https://www.ncbi.nlm.nih.gov/snp/).
TABLE 3 | Distribution of rs10482605 and rs1360780 genotypes between cases
and controls.
Genotypes Cases, Controls P
n (%) n (%)
rs10482605 N = 309 N = 315
Wild type (AA) 232 (48.13) 250 (51.87) 0.369
Heterozygous (GA) 73 (54.89) 60 (45.11)
Mutant (GG) 4 (44.44) 5 (55.56)
rs1360780 n = 350 n = 335
Wild type (CC) 133 (52.36) 121 (47.64) 0.492
Heterozygous (CT ) 166 (51.88) 154 (48.13)
Mutant (TT ) 51 (45.95) 60 (54.05)
n, number of participants; %, percentage.
inTable 4 (P= 0.001).Moderate chronic stress appears to protect
against IDs (P = 0.026).
We interrogated the data to further assess whether individuals
carrying the polymorphic risk variants (we predicted that
these participants would be more vulnerable to the effect
of environmental adversity) are more likely to develop
psychopathology. All the environmental adversities assessed
were summed up and dichotomized as chronic or recent stress
as described. Using likelihood ratio analysis, there was no
significant association between gene–environment interactions
and susceptibility to IDs (P > 0.050), as shown in Table 5.
DISCUSSION
This study determined the allele and genotype frequencies
of SNPs in NR3C1 (rs10482605) and FKBP5 (rs1360780) and
examined the relationship between these SNPs, environmental
stress, and vulnerability to IDs in CA-HIV in Kampala and
Masaka districts in Uganda. The minor allele frequencies of
rs10482605 and rs1360780 polymorphisms were 0.121 and 0.396,
respectively, among this study population. The rs1360780 minor
allele frequency of 0.396 is similar to the 0.39–0.45 documented
in African Americans (40) but somewhat higher than those
in Estonian, Swedish, and Siberian populations. Similarly, the
rs10482605 minor allele frequency of 0.121 is higher than the
global and African minor allele frequencies reported in the 1,000
Genomes, equal to those in the Estonians (0.12) and Swedish
(0.13) but lower than those in the Siberian (0.50) populations.
The inconsistencies in polymorphism frequencies might be
TABLE 4 | Association between chronic and recent stress and internalizing
disorders (IDs) in children and adolescents living with human immunodeficiency
virus from Kampala and Masaka Districts—Uganda.
Predictors of IDs n = 309




Moderate 0.69 (0.49–0.95) 0.025a
Severe 0.92 (0.61–1.37) 0.673
Recent stress
Mild 1.0 Reference
Moderate 1.07 (0.76–1.52) 0.687
Severe 1.85 (1.29–2.65) 0.001a
Genotype
NR3C1 rs10482605
Wild type (AA) 1.0 Reference
Heterozygous (GA) 1.34 (0.91–1.99) 0.140
Mutant (GG) 0.73 (0.19–2.81) 0.649
FKBP5 rs1360780
Wild type (CC) 1.0 Reference
Heterozygous (CT ) 1.08 (0.76–1.55) 0.636
Mutant (TT ) 0.78 (0.48–1.27) 0.329
CI, confidence interval; OR, odds ratio.
aStatistically significant.
due to genetic ancestry-related differences and reinforces the
importance of studying genetically driven susceptibility to
disorders in diverse populations. Our result show that AA was
the most prevalent genotype of the rs10482605 SNP with a
frequency of 77.2%, whereas the frequency of the minor GG
genotype was 1.44%. This finding mirrors the frequencies of
93.1, 1.6, and 5.3% for AA, AG, and GG, respectively, reported
among the Chinese population (41). However, this result conflicts
with a previous study conducted in a German population where
genotype frequencies of 67, 27.6, and 4.4% for GG, AG, and
AA, respectively, were reported (42). These similarities and
differences are probably due to differences in ancestry. With
regards to the rs1360780 SNP in our sample, the following
genotype frequencies of 37.0, 46.7, and 16.3% for CC, CT, and
TT, respectively, were reported. Schneider et al. (42) also reported
similar findings among the German population.
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TABLE 5 | Gene-environment interaction.
Gene-environment interaction OR (95% CI) P Overall P
rs10482605 × chronic stress (N = 624)
AA—mild chronic stress 1.0 Reference 0.340
GA—moderate chronic stress 2.56 (105–6.24) 0.039
GA—severe chronic stress 1.36 (0.49–3.76) 0.549
GG—moderate chronic stress 0.765 (0.19–30.6) 0.887
GG—severe chronic stress 1.09 (0.35–33.95) 0.959
rs10482605 × recent stress (N = 624)
AA—mild recent stress 1.0 Reference 0.553
GA—moderate recent stress 0.828 (0.33–2.07) 0.687
GA—severe recent stress 1.75 (0.64–4.75) 0.270
GG—moderate recent stress 0.939 (0.06–13.9) 0.964
GG—severe recent stress 1.00 omitted
rs1360780 × chronic stress (N = 685)
CC—mild chronic stress 1.0 Reference 0.743
CT—moderate chronic stress 1.41 (0.673–2.962) 0.361
CT—severe chronic stress 1.59 (0.629–4.039) 0.325
TT—moderate chronic stress 0.83 (0.297–2.336) 0.728
TT—severe chronic stress 1.2 (0.359–4.01) 0.767
rs1360780 × recent stress (N = 685)
CC—mild recent stress 1.0 Reference 0.2628
CT—moderate recent stress 2.44 (1.086–5.50) 0.031
CT—severe recent stress 1.17 (0.52–2.63) 0.701
TT—moderate recent stress 1.41 (0.487–4.101) 0.523
TT—severe recent stress 0.894 (0.286–2.795) 0.848
CI, confidence interval; OR, odds ratio.
The distribution as well as the role of the genotypes
discussed above in vulnerability to IDs was investigated using
a case–control study design. Overall, there was no significant
difference in genotype distribution/frequencies between case
and control populations for both rs10482605 and rs1360780.
Remarkably, there was no association between the carriage of
the rs10482605 polymorphic G risk allele in this population and
vulnerability to IDs, consistent with previous studies among child
psychiatric population (43) and the Chinese Han population (41).
However, the rs10482605 polymorphism, which is in linkage
disequilibrium with rs6198, is associated with increased GR
beta mRNA stability, and previous authors have reported the
indirect effects of this gene with the IDs of depression and
anxiety (26, 42). Possession of the rs10482605 risk allele was
associated with childhood mood disorders in a mixed Canadian
population (44) and recurrent major depression in Belgian and
Swedish populations (43). Recently, Womersley et al. in South
Africa, reported that the rs10482605 risk allele was associated
with increased sensitivity to anxiety among adolescents (45).
In this study, the proportion of participants carrying the TT
polymorphic risk allele of rs1360780, which is located in intron
2 of FKBP5, did not differ significantly between cases and
controls. Schneider et al. in a study among pregnant women in
Germany, observed no association between polymorphisms in
the FKBP5 gene and depressive scores (42). Other researchers,
however, have reported conflicting results. Menke et al. reported
a significant association between the TT FKBP5 alleles and
depression among an adult German population (46). Binder
et al. in another German study, reported a significant association
between polymorphisms in the FKBP5 gene and the recurrence
of depressive episodes and response to antidepressants (47).
In a European study conducted among depression treatment-
resistant adolescents, FKBP5 rs1360780 was associated with
suicide, a distal correlate of depression (48). It is plausible
that the rs1360780 and rs10482605 polymorphisms may not
be involved in the pathophysiology of IDs in CA-HIV in the
Ugandan population.
There are a number of possible reasons for these discrepant
results. Firstly, on a more general conceptual level, the IDs
of depression and anxiety have a multi-factorial etiology that
includes biological (including genetic) and environmental risk
factors (5, 9, 49, 50). It is now believed that the predisposition
to IDs, such as depression, is determined by the coordinated
action of many genes and their interaction with each other and
with diverse environmental factors (51). We did not observe
any gene–environment effect on vulnerability to IDs in this
population. It is also likely that each gene, by itself, makes a
relatively small contribution to the pathogenesis of the disease
(52). As a result of this and as shown in this study, it has been
difficult to replicate genetic associations. Shadrina et al. (51), in
a recent review article, highlighted the challenges of replicating
genetic association studies despite the fact that a large number of
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the associations between genes and different clinical depression
variants and depressive sub-phenotypes have been published.
Secondly, another reason for the discrepant results could
be methodological; the sample size for this study may have
been inadequate to identify the small contribution that each
of these SNPs is hypothesized to contribute to the risk of
the IDs of depression and anxiety. Hence, this study was
probably not adequately powered to test the association between
these SNPs and IDs. This observation is supported by recent
efforts to identify common genetic variants associated with
depression in genome-wide association studies (GWAS), which
have previously been unsuccessful largely because of inadequate
samples. In a recent successful GWAS, in order to maximize
the sample size, Howard et al. (49), in a meta-analysis, used
data on 807,553 individuals (246,363 cases and 561,190 controls)
and were able to identify 102 independent variants associated
with depression. Lastly, another factor that may have contributed
to the absence of an association between the investigated SNPs
and IDs is the differences in participant ancestry between this
and previous studies. While this study was undertaken among
respondents of African ancestry, all the previous studies that
reported positive results were of Caucasian ancestry (46–48). It
is possible that it is not the rs1360780 and rs10482605 SNPs
themselves that increase the risk for IDs but rather another
variant or variants that are in close linkage disequilibrium
(53). Ancestry-based differences in haplotype structure may thus
account for discrepant findings across different study groups.
Furthermore, ancestry may also affect the degree to which genetic
variants play a role in determining local and more distal gene
expression (54).
In this study, we found an association between IDs and
both recent and chronic stress. The odds of IDs increased with
increasing severe recent stress and decreased with moderate
chronic stress. This finding is consistent with previous studies
where recent stress has been associated with the IDs of depression
(9, 55) and anxiety (56). Interestingly, the odds of developing
IDs decreased with moderate chronic stress in CA-HIV. The
seemingly protective effect of moderate chronic stress in this
study could not be easily explained but could be attributed
to physiological and biochemical cross-adaptations. Moderate
chronic stress has also been shown to be associated with
alleviation of depressive symptoms in open water swimmers
(57). However, a recent study in animal models showed that, in
young adult female mice, chronic stress resulted in decreased
anxiety-like behavior and enhanced cognitive performance,
whereas in old female mice it led to weight loss, dysregulated
locomotion, and memory impairment, suggesting that the effect
of chronic stress on behavior is age dependent (58). These
results may have underlined the findings in our study as the
study respondents were relatively very young (aged between
5 and 17 years). Further empirical evidence is warranted
to understand the mechanisms underpinning the observed
positive clinical effect. This could revolutionize the extant
therapies and lead to potential non-drug pathways to recovery
from IDs.
In conclusion, the results from this study seem to give
credence to the stress-vulnerability diathesis of depression as
postulated by Ising and Holsboer (59), where acute and chronic
stress were both associated with IDs. However, in departure
from the stress-vulnerability diathesis of Ising and Holsboer
(59), moderate chronic stress among young respondents in
this study seemed to be protective against IDs. These results,
however, need to be replicated by further studies. Additionally,
while the results from this study showed the contribution of
psychosocial stressors on ID vulnerability, they did not show
a contribution of genetic factors to vulnerability as originally
hypothesized. We interrogated the data to further assess whether
individuals carrying the polymorphic risk variants (we predicted
that these participants would be more vulnerable to the effect
of environmental adversity) were more prone to developing a
psychopathology. Using logistic regression analysis, there was
no significant association between gene–environment interaction
and susceptibility to IDs.
The study has some limitations: (1) recall bias: the number and
nature of adverse environmental episodes in the past month were
obtained retrospectively from caregivers and participants (in the
parent CHAKA study) by a psychiatric clinician during history
taking. Studies have shown that the retrospective reporting
of childhood trauma is valid (60) and is not influenced by
psychiatric state at the time of the report (61). In this regard,
it is noteworthy that all the participants were interviewed using
standardized tools and by trained psychiatric clinicians; (2) study
design: the study sample was small, given the relatively small
contribution that each SNP makes to the risk of depression.
Furthermore, our study was limited to two SNPs. Though
these were selected based on previous publications, the more
comprehensive, and expensive, genome- or transcriptome-wide
approaches are better suited to investigating the role of multiple
genetic variants in complex disorders such as IDs; and (3) control
group composition: we acknowledge that factors such as ART
could associate with ID status and influence the study findings.
We also acknowledge that HIV positivity status constitutes
a chronic stressor through the persistent disturbance of the
immune, cardiovascular, metabolic, and behavioral homeostasis
(62). However, any potential confounding effect of HIV diagnosis
on the qualification of chronic stress in this study is buffered
out by the fact that both cases and controls were HIV-
positive. Nonetheless, this study would be preferred among a
general population; but, since it was nested in a parent study
which investigated psychiatric disorders among Ugandan HIV+
children and adolescents, the clinical data and sample available to
us was in this cohort.
CONCLUSION
Neither of the SNPs investigated in this study was significantly
associated with vulnerability to IDs. However, as previously
reported by others, severe recent stress was a significant risk
factor of IDs. Additionally, in this study, moderate chronic stress
seemed to be a protective factor against IDs, an observation that
has only been previously reported in animal models. We did not
observe any gene–environment effect on vulnerability to IDs in
this population.
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RECOMMENDATION
There is a need to undertake a GWAS to illuminate the role
of genetic factors in the risk of IDs among respondents of
African ancestry. The observation of the possible protective role
against IDs of moderate chronic stress among relatively young
respondents observed in this study warrants further inquiry.
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